Results
1 -
10 of
14Hypoxia-Directed Drug Strategies to Target the Tumor Microenvironment, Tumor Microenvironment and Cellular Stress Reductive metabolism of the dinitrobenzamide mustard anticancer prodrug PR-104 in mice, Cancer Chemotherapy and Pharmacology Prodrug Strategies for Targeting Tumour Hypoxia, Hypoxia and Cancer The Leukemic Bone Marrow Microenvironment: Targeting Hypoxia with Hypoxia-Activated Prodrugs, Targeted Therapy of Acute Myeloid Leukemia A phase I trial of PR-104, a nitrogen mustard prodrug activated by both hypoxia and aldo-keto reductase 1C3, in patients with solid tumors, Cancer Chemotherapy and Pharmacology Erratum to: Reductive metabolism of the dinitrobenzamide mustard anticancer prodrug PR-104 in mice, Cancer Chemotherapy and Pharmacology Targeting the hypoxic fraction of tumours using hypoxia-activated prodrugs, Cancer Chemotherapy and Pharmacology A combined pharmacokinetic model for the hypoxia-targeted prodrug PR-104A in humans, dogs, rats and mice predicts species differences in clearance and toxicity, Cancer Chemotherapy and Pharmacology Complete nucleotide sequence of Northern cereal mosaic virus and its genome organization, Archives of Virology